Items tagged with Access
TB CAB, TAG open letter to Janssen regarding the FDA approval of bedaquiline (post with simple image)
Determining a fair and affordable price of bedaquiline is essential for timely approval and appropriate domestic and global access to the best possible therapeutic options for people with DR-TB.
Janssen's response to open letter calling on the company to reduce the price of bedaquiline (post with simple image)
Several organizations and individuals working on TB appealed to Janssen to lower bedaquiline's price for all non-high-income countries.
Patients groups rally in Ukraine as government fails to conduct essential drug purchase tenders (post with simple image)
Hundreds of thousands of Ukrainian patients were left without drugs for treatment, when government did not manage to conduct tenders for 80% of drug purchases under the state health programmes, the joint press release from prominent patients organisations in Ukraine informs.
TAGline Fall 2014: hello generics (post with simple image)
News on the fight to end HIV/AIDS, viral hepatitis, and tuberculosis
TAG touts progress in global access to TB drugs (post with simple image)
TB advocacy campaigner Treatment Action Group (TAG) has reached a milestone in improving access to TB treatments.
South Africa: National Summit demands immediate patent law reform to bring down prices of medicines (post with simple image)
Patients, doctors and members of civil society meet with government experts to plot a course for quickly reforming South Africa’s patent laws, so that people can access the life-saving medicines they need at affordable prices.
South Africa: Bedaquiline approved to treat multidrug-resistant tuberculosis (post with simple image)
The Medicines Control Council has approved Janssen Pharmaceutica’s bedaquiline, the first drug specifically designed for treating multidrug-resistant tuberculosis (MDR-TB) to reach the market.
UNITAID Tuberculosis Medicines Technology and Market Landscape (second edition) (post with simple image)
The report details current shortcomings in the tuberculosis medicines market and opportunities to improve access to lifesaving TB treatment.
South Africa: Multinational pharmaceutical companies push back on new patent policy (post with simple image)
As extensively drug-resistant tuberculosis (XDR-TB) patients beg for a new patent policy to allow them affordable treatment, multinational pharmaceutical companies have objected to some of the draft policy’s key tenets.
Ensuring access to generic antiretroviral medicines in low- and middle-income countries (post with simple image)
The recent scale-up of the number of people living with HIV accessing antiretroviral therapy can be linked to the increased availability of generic antiretroviral medicines. Given that people living with HIV will need life-long access to such medicines, there is a need to scale up the research and development, production and distribution of generic antiretroviral medicines that are both effective and affordable.
Page 56 of 83 · Total posts: 0
←First 55 56 57 Last→